Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis
Titel:
Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis
Auteur:
Schwalm, Stephanie Beyer, Sandra Hafizi, Redona Trautmann, Sandra Geisslinger, Gerd Adams, David R. Pyne, Susan Pyne, Nigel Schaefer, Liliana Huwiler, Andrea Pfeilschifter, Josef